Literature DB >> 21344233

[Technical innovations and limitation in cardiac electrotherapy].

H-H Minden1.   

Abstract

Coronary sinus (CS) lead positioning is one of the main determinants of cardiac resynchronization therapy (CRT). The implantation of the CS lead is faced with several technical difficulties that may prevent the achievement of a stable position and good performance of the CS lead without phrenic nerve stimulation (PNS). New developments in catheter and lead technology to overcome these difficulties are presented.

Mesh：

Year:  2011        PMID： 21344233     DOI： 10.1007/s00399-011-0117-2

Source DB:  PubMed          Journal:  Herzschrittmacherther Elektrophysiol        ISSN： 0938-7412


  28 in total

1.  Cardiac resynchronization in chronic heart failure.

Authors:  William T Abraham; Westby G Fisher; Andrew L Smith; David B Delurgio; Angel R Leon; Evan Loh; Dusan Z Kocovic; Milton Packer; Alfredo L Clavell; David L Hayes; Myrvin Ellestad; Robin J Trupp; Jackie Underwood; Faith Pickering; Cindy Truex; Peggy McAtee; John Messenger
Journal:  N Engl J Med       Date:  2002-06-13       Impact factor: 91.245

2.  2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association.

Authors:  Kenneth Dickstein; Panos E Vardas; Angelo Auricchio; Jean-Claude Daubert; Cecilia Linde; John McMurray; Piotr Ponikowski; Silvia Giuliana Priori; Richard Sutton; Dirk J van Veldhuisen
Journal:  Eur Heart J       Date:  2010-08-27       Impact factor: 29.983

Review 3.  Lead positioning strategies to enhance response to cardiac resynchronization therapy.

Authors:  Dan Blendea; Jagmeet P Singh
Journal:  Heart Fail Rev       Date:  2011-05       Impact factor: 4.214

4.  Impact of segmental left ventricle lead position on cardiac resynchronization therapy outcomes.

Authors:  Faisal M Merchant; E Kevin Heist; David McCarty; Prabhat Kumar; Saumya Das; Dan Blendea; Patrick T Ellinor; Theofanie Mela; Michael H Picard; Jeremy N Ruskin; Jagmeet P Singh
Journal:  Heart Rhythm       Date:  2010-02-01       Impact factor: 6.343

5.  Safety of transvenous cardiac resynchronization system implantation in patients with chronic heart failure: combined results of over 2,000 patients from a multicenter study program.

Authors:  Angel R León; William T Abraham; Anne B Curtis; James P Daubert; Westby G Fisher; John Gurley; David L Hayes; Randy Lieberman; Susan Petersen-Stejskal; Kevin Wheelan
Journal:  J Am Coll Cardiol       Date:  2005-12-20       Impact factor: 24.094

6.  Implantable cardiac device procedures in older patients: use and in-hospital outcomes.

Authors:  Jason P Swindle; Michael W Rich; Patrick McCann; Thomas E Burroughs; Paul J Hauptman
Journal:  Arch Intern Med       Date:  2010-04-12

7.  The effect of cardiac resynchronization on morbidity and mortality in heart failure.

Authors:  John G F Cleland; Jean-Claude Daubert; Erland Erdmann; Nick Freemantle; Daniel Gras; Lukas Kappenberger; Luigi Tavazzi
Journal:  N Engl J Med       Date:  2005-03-07       Impact factor: 91.245

8.  Impact of tricuspid regurgitation and prior coronary bypass surgery on the geometry of the coronary sinus: a rotational coronary angiography study.

Authors:  Dan Blendea; E Kevin Heist; Saumya Das; Stephan Danik; Conor Barrett; Theofanie Mela; Jeremy N Ruskin; Jagmeet P Singh
Journal:  J Cardiovasc Electrophysiol       Date:  2009-11-10

9.  Prevalence and risk factors related to infections of cardiac resynchronization therapy devices.

Authors:  Cécile Romeyer-Bouchard; Antoine Da Costa; Virginie Dauphinot; Marc Messier; Laurence Bisch; Bernard Samuel; Patrick Lafond; Philippe Ricci; Karl Isaaz
Journal:  Eur Heart J       Date:  2009-10-28       Impact factor: 29.983

10.  Long-term retention of cardiac resynchronization therapy.

Authors:  Bradley P Knight; Aseem Desai; James Coman; Mitchell Faddis; Patrick Yong
Journal:  J Am Coll Cardiol       Date:  2004-07-07       Impact factor: 24.094
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.